Dearman Rebecca J, Beresford Lorna, Foster Emily S, McClain Scott, Kimber Ian
Faculty of Life Sciences, The University of Manchester, Michael Smith Building, Oxford Road, Manchester, M13 9PT, UK.
J Appl Toxicol. 2014 May;34(5):489-97. doi: 10.1002/jat.2897. Epub 2013 Jun 10.
Assessment of the potential allergenicity (IgE-inducing properties) of novel proteins is an important challenge in the overall safety assessment of foods. Resistance to digestion with pepsin is commonly measured to characterize allergenicity, although the association is not absolute. We have previously shown that specific IgE antibody production induced by systemic [intraperitoneal (i.p.)] exposure of BALB/c strain mice to a range of proteins correlates with allergenic potential for known allergens. The purpose of the present study was to explore further the utility of these approaches using the food allergen, actinidin. Recently, kiwifruit has become an important allergenic foodstuff, coincident with its increased consumption, particularly as a weaning food. The ability of the kiwifruit allergen actinidin to stimulate antibody responses has been compared with the reference allergen ovalbumin, and with the non-allergen bovine haemoglobin. Haemoglobin was rapidly digested by pepsin whereas actinidin was resistant unless subjected to prior chemical reduction (reflecting intracellular digestion conditions). Haemoglobin stimulated detectable IgG antibody production at relatively high doses (10%), but failed to provoke detectable IgE. In contrast, actinidin was both immunogenic and allergenic at relatively low doses (0.25% to 1%). Vigorous IgG and IgG1 antibody and high titre IgE antibody responses were recorded, similar to those provoked by ovalbumin. Thus, actinidin displays a marked ability to provoke IgE, consistent with allergenic potential. These data provide further encouragement that in tandem with analysis of pepsin stability, the induction of IgE after systemic exposure of BALB/c strain mice provides a useful approach for the prospective identification of protein allergens.
评估新型蛋白质的潜在致敏性(诱导IgE的特性)是食品整体安全性评估中的一项重要挑战。尽管这种关联并非绝对,但通常通过测量对胃蛋白酶消化的抗性来表征致敏性。我们之前已经表明,将BALB/c品系小鼠经腹腔内(i.p.)全身暴露于一系列蛋白质所诱导的特异性IgE抗体产生与已知过敏原的致敏潜力相关。本研究的目的是使用食品过敏原——猕猴桃蛋白酶进一步探索这些方法的实用性。最近,随着猕猴桃消费量的增加,尤其是作为断奶食品,它已成为一种重要的致敏性食品。将猕猴桃过敏原猕猴桃蛋白酶刺激抗体反应的能力与参考过敏原卵清蛋白以及非过敏原牛血红蛋白进行了比较。血红蛋白被胃蛋白酶迅速消化,而猕猴桃蛋白酶除非事先进行化学还原(反映细胞内消化条件),否则具有抗性。血红蛋白在相对高剂量(10%)时刺激产生可检测到的IgG抗体,但未能引发可检测到的IgE。相比之下,猕猴桃蛋白酶在相对低剂量(0.25%至1%)时具有免疫原性和致敏性。记录到强烈的IgG和IgG1抗体以及高滴度IgE抗体反应,类似于卵清蛋白引发的反应。因此,猕猴桃蛋白酶显示出明显的引发IgE的能力,与致敏潜力一致。这些数据进一步表明,与胃蛋白酶稳定性分析相结合,BALB/c品系小鼠全身暴露后IgE的诱导为前瞻性鉴定蛋白质过敏原提供了一种有用的方法。